These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8614383)

  • 1. "Chemotherapy for unresectable pancreatoblastoma".
    Hord JD; Janco RL
    Med Pediatr Oncol; 1996 Jun; 26(6):432-3. PubMed ID: 8614383
    [No Abstract]   [Full Text] [Related]  

  • 2. "Response to Hord and Janco re chemotherapy for unresectable pancreatoblastoma".
    Lee AC; Wong KW; Cheng MY
    Med Pediatr Oncol; 1997 Sep; 29(3):237. PubMed ID: 9212854
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
    Cocconi G; Bisagni G; Bella M; Acito L; Anastasi P; Carpi A; Di Costanzo F; Frassoldati A; Mosconi A; Borrini A; Buzzi P
    Am J Clin Oncol; 1999 Dec; 22(6):593-600. PubMed ID: 10597744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
    Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
    Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in advanced pancreatic adenocarcinoma.
    Kollmannsberger C; Peters HD; Fink U
    Cancer Treat Rev; 1998 Apr; 24(2):133-56. PubMed ID: 9728423
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reye syndrome in a child having received chemotherapy].
    Dubern B; Alessandri JL; Montbrun A; Attali T; Pilorget H; Samperiz S
    Arch Pediatr; 1998 Mar; 5(3):342-3. PubMed ID: 10328010
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet concentrate transfusion during polychemotherapy of children with solid tumors].
    Koposov PV; KovalevI VI; Strykov VA; Kovalev LV; Loseva MS; Starostina AIu; Prostomolotov OA; Zakharov MV
    Vopr Onkol; 2002; 48(3):365-8. PubMed ID: 12455364
    [No Abstract]   [Full Text] [Related]  

  • 10. CA and leukemia group B 9251 protocol.
    Zitter K; DeVos D
    Radiol Technol; 1997; 68(5):423-5. PubMed ID: 9170185
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute mesenteric ischaemia associated with 5-FU, cisplatin and vincristine chemotherapy.
    Allerton R
    Clin Oncol (R Coll Radiol); 1996; 8(2):116-7. PubMed ID: 8859610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
    Berruti A; Tampellini M; Gorzegno G; Dogliotti L
    Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ; Moore CL; Anderson NR
    Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The update on pancreatic cancer chemotherapy].
    Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A
    Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
    Fierro MT; Doveil GC; Quaglino P; Savoia P; Verrone A; Bernengo MG
    Dermatology; 1997; 194(3):268-72. PubMed ID: 9187846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full chemotherapy in elderly patients with small cell bronchial carcinoma.
    Nõu E
    Acta Oncol; 1996; 35(4):399-406. PubMed ID: 8695151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.
    Onda T; Yoshikawa H; Yasugi T; Mishima M; Nakagawa S; Yamada M; Matsumoto K; Taketani Y
    Cancer; 1998 Oct; 83(8):1555-60. PubMed ID: 9781949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.